Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Purpose The aim of this study was to investigate the feasibility of assessing dopamine transporter binding after treatment with methylphenidate in the rat using a recently developed high-resolution small animal single-photon emission computed tomograph (TierSPECT) and [123I]FP-CIT.Methods [123I]FP-CIT was administered intravenously 1 h after intraperitoneal injection of methylphenidate (10 mg/kg) or vehicle. Animals underwent scanning 2 h after radioligand administration. The striatum was identified by superimposition of [123I]FP-CIT scans with bone metabolism and perfusion scans obtained with 99mTc-DPD and 99mTc-tetrofosmin, respectively. As these tracers do not pass the blood-brain barrier, their distribution permits the identification of extracerebral anatomical landmarks such as the orbitae and the harderian glands. The cerebellum was identified by superimposing [123I]FP-CIT scans with images of brain perfusion obtained with 99mTc-HMPAO.Results Methylphenidate-treated animals and vehicle-treated animals yielded striatal equilibrium ratios (V''3) of 0.24+/-0.26 (mean +/- SD) and 1.09+/-0.42, respectively (t test, two-tailed, p<0.0001). Cortical V''3 values amounted to 0.05+/-0.28 (methylphenidate) and 0.3+/-0.39 (saline, p=0.176). This first in vivo study of rat dopamine transporter binding after pre-treatment with methylphenidate showed a mean reduction of 78% in striatal [123I]FP-CIT accumulation.Conclusion The results can be interpreted in terms of a pharmacological blockade in the rat striatum and show that in vivo quantitation of dopamine transporter binding is feasible with [123I]FP-CIT and the TierSPECT. This may be of future relevance for in vivo investigations on rat models of attention deficit/hyperactivity disorder. Furthermore, our findings suggest that investigations in other animal models, e.g. of Parkinson's and Huntington's disease, may be feasible using SPECT radioligands and small animal imaging systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885 · cited 2×
“Following pre-treatment with methylphenidate, specific DAT binding of [11C]cocaine and 99mTc-([2-[[2[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2yl]methyl](2-mercapoethyl)amino]ethyl]-amino]-ethanetio-lato-(3-)]-oxo-[1R-(exo-exo)]) (99mTc-TRODAT) was shown to be reduced in both ADHD patients [4] and normal c…”
MethodResultInfluentialDopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684 · cited 1×
“Following pre-treatment with methylphenidate, specific DAT binding of [11C]cocaine and 99mTc-([2-[[2[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2yl]methyl](2-mercapoethyl)amino]ethyl]-amino]-ethanetio-lato-(3-)]-oxo-[1R-(exo-exo)]) (99mTc-TRODAT) was shown to be reduced in both ADHD patients [4] and normal c…”
MethodInfluentialKrause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 2×
“Following pre-treatment with methylphenidate, specific DAT binding of [11C]cocaine and 99mTc-([2-[[2[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2yl]methyl](2-mercapoethyl)amino]ethyl]-amino]-ethanetio-lato-(3-)]-oxo-[1R-(exo-exo)]) (99mTc-TRODAT) was shown to be reduced in both ADHD patients [4] and normal c…”
MethodResultInfluentialRobinson, T. E., Gorny, G., Mitton, E., & Kolb, B. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<257::aid-syn1007>3.0.co;2-1 · Cited by 402
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353 · cited 2×
“Following pre-treatment with methylphenidate, specific DAT binding of [11C]cocaine and 99mTc-([2-[[2[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2yl]methyl](2-mercapoethyl)amino]ethyl]-amino]-ethanetio-lato-(3-)]-oxo-[1R-(exo-exo)]) (99mTc-TRODAT) was shown to be reduced in both ADHD patients [4] and normal c…”
BackgroundMethodInfluentialDresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278 · cited 1×
“Following pre-treatment with methylphenidate, specific DAT binding of [11C]cocaine and 99mTc-([2-[[2[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2yl]methyl](2-mercapoethyl)amino]ethyl]-amino]-ethanetio-lato-(3-)]-oxo-[1R-(exo-exo)]) (99mTc-TRODAT) was shown to be reduced in both ADHD patients [4] and normal c…”
MethodInfluentialSeibyl, J. P., MAREK, K. L., Sheff, K., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., van Dyck, C. H., & Innis, R. B. (1998) · PubMed · Cited by 164
An introduction to PET and SPECT neuroreceptor quantification models.
Ichise, M., Meyer, J. H., & Yonekura, Y. (2001) · PubMed · Cited by 158
Evaluation of high-resolution pinhole SPECT using a small rotating animal.
Habraken, J. B. A., de Bruin, K. M., Shehata, M., Booij, J., Bennink, R. J., van Eck‐Smit, B. L. F., & Sokole, E. B. (2001) · PubMed · Cited by 129
Booij, J., Hemelaar, T. G., Speelman, J. D., de Bruin, K. M., Janssen, A. G. M., & van Royen, E. A. (1999) · PubMed · Cited by 120
Research works printed but not linked: 1
- Nikolaus S, Wirrwar A, Klimke A, Beu M, Forutan F, Vosberg H, et al. State-of-the-art in high-resolution imaging of small animals with PET and SPECT. In: Mohan RM, editor. Research advances in nuclear medicine. Kerala: Global Research Networks; 2002. p. 13?29.
Cited by
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…NE to bind to their respective transporters (i.e., the DAT or NET) or to DA or NE receptors, as evidenced by reductions in ligand binding in PET and SPECT studies (Ding et al., 1997; Dresel et al., 1999; Gatley et al., 1999; Nikolaus et al., 2005, Nikolaus et al., 2007, 2011; Volkow et al., 1999a).”
Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
Franc, B. L., Acton, P. D., Mari, C., & Hasegawa, B. H. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055442 · Cited by 242
“The quantitative ability of SPECT in this application has been used in measuring 123I-N-v-fluoropropyl-2b-carbomethoxy3b-(4-iodophenyl)-nortropane (123I-FP-CIT) binding to dopamine transporters (DATs) in the rat brain after treatment with methylphenidate (31).”
MethodAnimal models concerning the role of dopamine in attention-deficit hyperactivity disorder
van der Kooij, M. A., & Glennon, J. C. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.12.002 · Cited by 142
Alvarez‐Fischer, D., Blessmann, G., Trosowski, C., Béhé, M. P., Schurrat, T., Hartmann, A., Behr, T. M., Oertel, W. H., Höglinger, G. U., & Höffken, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.05.056 · Cited by 46
“SPECT imaging of the brain has already been used successfully before in small animals (Habraken et al., 2001; Scherfler et al., 2002, 2005; Andringa et al., 2005; Nikolaus et al., 2005).”
Yeh, C.-B., Lee, C.-S., Ma, K.-H., Lee, M.-S., Chang, C.-J., & Huang, W.-S. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2007.01.003 · Cited by 41
Pinhole SPECT Reconstruction Using Blobs and Resolution Recovery
Andreyev, A., Defrise, M., & Vanhove, C. (2006) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2006.878004 · Cited by 41
SPECT neuroimaging in translational research of CNS disorders
Sharma, S. K., & Ebadi, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.08.011 · Cited by 40
Hesse, S., Strecker, K., Winkler, D. F. H., Luthardt, J., Scherfler, C., Reupert, A., Oehlwein, C., Barthel, H., Schneider, J. ‐., Wegner, F., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0849-z · Cited by 31
“of brain perfusion/neuronal activity [26, 35].”
Nikolaus, S., Larisch, R., Wirrwar, A., Jamdjeu-Nouné, M., Antke, C., Beu, M., Schramm, N. U., & Müller, H. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1839-3 · Cited by 29
“Therefore, investigators commonly apply the single bolus paradigm [2, 4, 5]; the sole exceptions are the murine studies of Acton and collaborators, who were able to use the constant infusion paradigm as their investigations were performed with a conventional clinical three-head scanner allowing dynamic acquisition of…”
BackgroundMethodSelf-citationA compact gamma camera for biological imaging
Bradley, E. L., Cella, J., Majewski, S., Popov, V., Qian, J., Saha, M. S., Smith, M. F., Weisenberger, A. G., & Welsh, R. E. (2006) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2005.862977 · Cited by 24
Nikolaus, S., Antke, C., Kley, K., Beu, M., Wirrwar, A., & Müller, H. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.061952 · Cited by 23
“On 3 other animals, images of bone metabolism, soft-tissue perfusion, and brain perfusion were acquired to delineate the striatal and cerebellar target regions, as previously published (17,20).”
Self-citationNikolaus, S., Antke, C., Beu, M., Kley, K., Larisch, R., Wirrwar, A., & ller, H.-W. M. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328014a0df · Cited by 24
Self-citationNikolaus, S., Larisch, R., Vosberg, H., Beu, M., Wirrwar, A., Antke, C., Kley, K., Silva, M. A. D. S., Huston, J. P., & Müller, H. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.054 · Cited by 19
Self-citationChallenge by the murine brain: Multi-pinhole SPECT of 123I-labelled pharmaceuticals
Pissarek, M., Oros‐Peusquens, A., & Schramm, N. U. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.10.011 · Cited by 17
Self-citationDiagnostic accuracy of FP-CIT SPECT in patients with Parkinsonism
Lozano, S. J. O., Torres, M. D. M. D. V., García, J. M. J.-H., Cardo, A. L. G., & Arillo, V. M. C. (2007) · Revista Española de Medicina Nuclear · doi:10.1016/s1578-200x(07)70062-1 · Cited by 18
Qu, S., Zhou, X., Wang, Z., Yi, W., Zhou, H., Zhang, X., Zhu, Q., Wang, Y., Yang, Q., Jiang, L., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02314-6 · Cited by 14
D’Elia, A., Schiavi, S., Soluri, A., Massari, R., Soluri, A., & Trezza, V. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.596509 · Cited by 14
Utilidad diagnóstica de la SPECT con FP-CIT en el estudio de pacientes con parkinsonismo
Lozano, S. J. O., Torres, M. D. M. D. V., García, J. M. J.-H., Cardo, A. L. G., & Arillo, V. M. C. (2007) · Revista Española de Medicina Nuclear · doi:10.1157/13109142 · Cited by 12
Farias, T. L., Marinho, V., Carvalho, V., Rocha, K. D. M., da Silva, P. R. A., Silva, F. J. D. C., Teles, A. S., Gupta, D. S., Ribeiro, P. F. M., Velasques, B., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-018-3699-1 · Cited by 10
In vivo snapshots of the dopaminergic synapse in small animals
Nikolaus, S., Beu, M., Wirrwar, A., Antke, C., & Müller, H.-W. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001693 · Cited by 10
Self-citationNikolaus, S., Antke, C., Beu, M., Kley, K., Wirrwar, A., Huston, J. P., & Müller, H. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1668-x · Cited by 10
“29, Advanced Tomo Vision GmbH, Kerpen, Germany) as previously described [17–19].”
InfluentialSelf-citationFrankl, J. A., Bose, S., & Kuo, P. H. (2017) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.117.201558 · Cited by 6
“Our findings are consistent with animal models showing that methylphenidate—which, like dextroamphetamine and amphetamine, reduces dopamine transporter availability—decreases the dopamine transporter SPECT signal (4).”
ResultSmall-Animal SPECT, SPECT/CT, and SPECT/MRI
Meng, L.-J., & Clinthorne, N. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00007-7 · Cited by 4
Roé-Vellvé, N., Pino, F., Falcón, C., Cot, A., Gispert, J. D., Marín, C., Pavía, J., & Ros, D. (2014) · Physics in Medicine and Biology · doi:10.1088/0031-9155/59/16/4567 · Cited by 4
Nikolaus, S., Wirrwar, A., Larisch, R., Schramm, N. U., Antke, C., & Müller, H. (2005) · IEEE Symposium Conference Record Nuclear Science 2004. · doi:10.1109/nssmic.2004.1466364 · Cited by 3
Self-citationNanosized drug delivery systems as radiopharmaceuticals
Silindir‐Gunay, M., & Özer, A. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00022-2 · Cited by 6
BrainPET Poster Session: Molecular Brain Imaging—Clinical Applications
(2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.171
Metadata
- Authors
- Nikolaus, S., Wirrwar, A., Antke, C., Arkian, S., Schramm, N., M�ller, H.-W., & Larisch, R.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- Forschungszentrum Jülich (DE)
- Corresponding author
- Nikolaus, Susanne
- ORCID
- Nikolaus, Susanne
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2004-10-12
- Volume
- 32
- Issue
- 3
- Pages
- 308-313
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W1977831777
- Cited by
- 29
- References
- 22
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2014: 1 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- dopamine transporter, methylphenidate, 123I-FP-CIT, small animal SPECT, striatum, attention deficit hyperactivity disorder, rat model, Parkinson's disease, Huntington's disease, brain perfusion imaging
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Equipment Design, Feasibility Studies, Image Interpretation, Computer-Assisted, Iodine Radioisotopes, Male, Membrane Glycoproteins, Methylphenidate, Nerve Tissue Proteins, Sensitivity and Specificity, Tissue Distribution, Tropanes, Reproducibility of Results, Tomography, Emission-Computed, Single-Photon, Rats, Wistar, Radiopharmaceuticals, Equipment Failure Analysis, Membrane Transport Proteins, Membrane Transport Modulators, Dopamine Plasma Membrane Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.